SARS CoV-2 Infection
7
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease
Evaluation of the Relationship of Vitamin D and Vitamin D Binding Protein with Disease Severity in Pediatric Sars-CoV2
Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients
Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)